Overview:
Immunization through vaccines are done to raise the immune responses leading to the generation of antibodies or cell-mediated responses that would combat infectious agents or any noninfectious conditions. The most critical factor for the successful immunization is to choose the route of administration by which a vaccine is brought into contact with the body. The vaccine delivery system helps to lower the spread of infection, enhance efficiency of vaccine administration and increase disease management by evoking better immune responses. The global vaccine delivery device market is segmented on the basis of route of administration such as intramuscular (IM) injection, subcutaneous (SC) injection, intradermal (ID) injection, oral route and intranasal (IN) route. The global vaccine delivery device is also segmented on the basis of products such as needle free syringes or jet injectors, electroporation devices, microneedles, aerosol/dry powder inhalation, biodegradable implants or bioneedles, prefilled reconstitution devices and prefilled syringes. The market of needle free syringes are expected to grow as it avoids the injury and pain caused by needle stick, it is proven to be safe and also reduces healthcare cost. There are almost 2-3 million needle-stick injuries being reported every year around the world and in US, about $3 billion is spent for its treatment.
Increasing inoculation programs and their expanding scope, developing examination in the field of immunization, expanding government support and speculation, continuous innovation in delivery systems, increasing vaccination activities and campaigns, and growing prevalence of infectious disease all globally can be attributed to the development of the vaccine delivery device market. Developing research in the field of antibodies, investment for R&D and improvement of new vaccine technologies is additionally adding to the development of vaccine delivery devices market.
Inappropriate training and unavailability of health care workers, resource unavailability for routine, inappropriate vaccine management, needle stick injuries to health care personnel, risk of infections and transmission of blood-borne infections due to improper sterilization of needles and disposal of sharps waste in community create some challenges to vaccine delivery devices market.
The North America holds the major share due to its well-established healthcare infrastructure, health conscious public and highly trained healthcare professionals. The market in Asia Pacific is anticipated to grow faster due to a large patient pool, unhealthy lifestyle, rising in geriatric population who are prone to infectious diseases and developing infrastructure in the region. The vaccination initiatives taken by organizations like CDC, PATH, GAVI also fuel the growth of the vaccine delivery device market globally.
The Global Vaccine Delivery Device Market is segmented on the following bases:
Global Vaccine Delivery Devices Market Revenue (US$ Mn), By Product Type, 2015-2025
- Needle free syringes or Jet injectors
- Electroporation
- Microneedles
- Aerosol/dry powder inhalation
- Biodegradable implants or bioneedles
- Prefilled reconstitution devices
- Prefilled syringes
Global Vaccine Delivery Devices Market Revenue (US$ Mn), By Route of Administration, 2015-2025
- Intramuscular (IM)
- Subcutaneous (SC)
- Intradermal (ID)
- Oral
- Intranasal (IN)
Global Vaccine Delivery Devices Market Revenue (USD Mn), By Geography, 2015-2025
- North America
- Europe
- UK
- Germany
- Rest of Europe
- Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of LATAM
- Middle East and Africa
- GCC
- South Africa
- Rest of MEA
Key Players Identified for Vaccine Delivery Device Market include:
Few major players in Vaccine Delivery Device Market include Becton Dickinson & Company, Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.), PharmaJet, Inc., Vaxxas, Gerresheimer AG, SCHOTT AG, Corium International, Inc., 3M, NanoPass, West Pharmaceutical Services, Inc. (West), Valeritas, Antares Pharma, Inc., Bioject Medical Technologies, Inc., Glide Pharmaceutical Technologies Ltd., Zogenix, Inc., Akra Dermojet, Injex Pharma AG, PenJet Corporation, and D’Antonio Consultants International, Inc. and others.
This report offers:
- An overview of the global markets for Vaccine Delivery Device Market.
- Market trends assessment for the period 2015-2025, with historical information for 2015 & 2016, and projections through 2025, with respective CAGRS during 2017-2025.
- Qualitative assessment tools such as market drivers, challenges and future prospects.
- Market competition scrutiny tools such as market share analysis, fractal map assessment.
- Focus on each level of market segmentation based on product approvals, launch, and current and anticipated market dynamics.
- A general overview of the industry structure.
- Company profiles highlighting key information about the major players operating in the Vaccine Delivery Device Market.
